Literature DB >> 21601658

Contributions of vascular inflammation in the brainstem for neurogenic hypertension.

Hidefumi Waki1, Sabine S Gouraud, Masanobu Maeda, Mohan K Raizada, Julian F R Paton.   

Abstract

Essential hypertension is idiopathic although it is accepted as a complex polygenic trait with underlying genetic components, which remain unknown. Our supposition is that primary hypertension involves activation of the sympathetic nervous system. One pivotal region controlling arterial pressure set point is nucleus tractus solitarii (NTS). We recently identified that pro-inflammatory molecules, such as junctional adhesion molecule-1, were over expressed in endothelial cells of the microvasculature supplying the NTS in an animal model of human hypertension (the spontaneously hypertensive rat: SHR) compared to normotensive Wistar Kyoto (WKY) rats. We have also shown endogenous leukocyte accumulation inside capillaries within the NTS of SHR but not WKY rats. Despite the inflammatory state in the NTS of SHR, transcripts of some inflammatory molecules such as chemokine (C-C motif) ligand 5 (Ccl5), and its receptors, chemokine (C-C motif) receptor 1 and 3 were down-regulated in the NTS of SHR compared to WKY rats. This may be compensatory to avoid further strong inflammatory activity. More importantly, we found that down-regulation of Ccl5 in the NTS of SHR may be pro-hypertensive since microinjection of Ccl5 into the NTS of SHR decreased arterial pressure but was less effective in WKY rats. Leukocyte accumulation of the NTS microvasculature may also induce an increase in vascular resistance and hypoperfusion within the NTS; the latter may trigger release of pro-inflammatory molecules which via paracrine signaling may affect central neural cardiovascular activity conducive to neurogenic hypertension. All told, we suggest that vascular inflammation within the brainstem contributes to neurogenic hypertension by multiple pathways.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21601658     DOI: 10.1016/j.resp.2011.05.004

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  33 in total

1.  Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation.

Authors:  Bevyn Jarrott; Spencer J Williams
Journal:  Neurochem Res       Date:  2015-07-16       Impact factor: 3.996

Review 2.  Macrophages under pressure: the role of macrophage polarization in hypertension.

Authors:  Sailesh C Harwani
Journal:  Transl Res       Date:  2017-11-08       Impact factor: 7.012

Review 3.  Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

Review 4.  Blood-brain barrier dysfunction: the undervalued frontier of hypertension.

Authors:  Vasiliki Katsi; Maria Marketou; Spyridon Maragkoudakis; Matthaios Didagelos; Georgios Charalambous; Fragkiskos Parthenakis; Costas Tsioufis; Dimitrios Tousoulis
Journal:  J Hum Hypertens       Date:  2020-05-18       Impact factor: 3.012

5.  Effect of centrally acting angiotensin converting enzyme inhibitor on the exercise-induced increases in muscle sympathetic nerve activity.

Authors:  Gilbert Moralez; Noah P Jouett; Jun Tian; Matthew C Zimmerman; Paul Bhella; Peter B Raven
Journal:  J Physiol       Date:  2018-05-15       Impact factor: 5.182

6.  MicroRNA network changes in the brain stem underlie the development of hypertension.

Authors:  Danielle DeCicco; Haisun Zhu; Anthony Brureau; James S Schwaber; Rajanikanth Vadigepalli
Journal:  Physiol Genomics       Date:  2015-06-30       Impact factor: 3.107

Review 7.  Neurogenic hypertension: revelations from genome-wide gene expression profiling.

Authors:  Francine Z Marques; Brian J Morris
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 8.  Rostral Ventrolateral Medulla and Hypertension.

Authors:  Patrice G Guyenet; Ruth L Stornetta; Benjamin B Holloway; George M P R Souza; Stephen B G Abbott
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

Review 9.  Blood pressure regulation XI: overview and future research directions.

Authors:  Peter B Raven; Mark W Chapleau
Journal:  Eur J Appl Physiol       Date:  2014-01-28       Impact factor: 3.078

Review 10.  Angiotensin-II, the Brain, and Hypertension: An Update.

Authors:  Colin N Young; Robin L Davisson
Journal:  Hypertension       Date:  2015-08-31       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.